IL226239B - Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same - Google Patents

Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same

Info

Publication number
IL226239B
IL226239B IL226239A IL22623913A IL226239B IL 226239 B IL226239 B IL 226239B IL 226239 A IL226239 A IL 226239A IL 22623913 A IL22623913 A IL 22623913A IL 226239 B IL226239 B IL 226239B
Authority
IL
Israel
Prior art keywords
dopa
inhibitors
catechol
compositions
same
Prior art date
Application number
IL226239A
Other languages
Hebrew (he)
Other versions
IL226239A0 (en
Inventor
Nemas Mara
Yacoby-Zeevi Oron
Original Assignee
Nemas Mara
Neuroderm Ltd
Oron Yacoby Zeevi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2011/000881 external-priority patent/WO2012066538A1/en
Application filed by Nemas Mara, Neuroderm Ltd, Oron Yacoby Zeevi filed Critical Nemas Mara
Priority to IL226239A priority Critical patent/IL226239B/en
Publication of IL226239A0 publication Critical patent/IL226239A0/en
Publication of IL226239B publication Critical patent/IL226239B/en

Links

IL226239A 2010-11-15 2013-05-08 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same IL226239B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL226239A IL226239B (en) 2010-11-15 2013-05-08 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41363710P 2010-11-15 2010-11-15
US201161524064P 2011-08-16 2011-08-16
PCT/IL2011/000881 WO2012066538A1 (en) 2010-11-15 2011-11-15 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
IL226239A IL226239B (en) 2010-11-15 2013-05-08 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same

Publications (2)

Publication Number Publication Date
IL226239A0 IL226239A0 (en) 2013-07-31
IL226239B true IL226239B (en) 2019-01-31

Family

ID=48917273

Family Applications (1)

Application Number Title Priority Date Filing Date
IL226239A IL226239B (en) 2010-11-15 2013-05-08 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same

Country Status (1)

Country Link
IL (1) IL226239B (en)

Also Published As

Publication number Publication date
IL226239A0 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
IL263954A (en) Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
ZA201109037B (en) Compositions for continuous administration of dopa decarboxylase inhibitors
ZA201206223B (en) Certain kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions, and methods of use thereof
ZA201401117B (en) Kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions,and methods of use thereof
IL253911A0 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
IL210843A0 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
IL220863A (en) Oxazole kinase inhibitors, pharmaceutical compositions comprising them and uses thereof
IL230705A0 (en) Certain kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions,and methods of use thereof
EP2534145A4 (en) Therapeutic methods and compositions involving allosteric kinase inhibition
EP3188725A4 (en) Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a comt inhibitor and method of administration thereof
IL223865B (en) Calcium salts of dihydroorotate dehydrogenase inhibitors, compositions comprising the same and uses thereof
PL2642993T3 (en) Compositions of rotigotine or pharmaceutically acceptable salts of rotigotine
TN2013000239A1 (en) New form of administration of enkephalinase inhibitor
EP2424533A4 (en) Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
IL226239B (en) Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
EP2588081A4 (en) Oral formulation of kinase inhibitors
HK1177101A (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed